PREDICTORS OF A FAVORABLE RESPONSE TO ALPHA INTERFERON THERAPY FOR HEPATITIS C
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 3 (4) , 775-791
- https://doi.org/10.1016/s1089-3261(05)70238-5
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CNew England Journal of Medicine, 1998
- Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.Journal of General Virology, 1998
- Iron and Chronic Viral HepatitisHepatology, 1997
- Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled studyJournal of Hepatology, 1996
- Ribavirin as Therapy for Chronic Hepatitis CAnnals of Internal Medicine, 1995
- Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.Journal of Clinical Investigation, 1995
- Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis CThe Journal of Pediatrics, 1994
- Measurements of iron status in patients with chronic hepatitisGastroenterology, 1992
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989